FDA’s drug quality report card details enforcement trends, increased inspections in 2022
Regulatory NewsJoanne S. Eglovitch
APIsBiologics/ biosimilars/ vaccinesBiotechnologyPharmaceuticalsRegulatory NewsJoanne S. EglovitchAPIsBiologics/ biosimilars/ vaccinesBiotechnologyPharmaceuticals